Aksh Optifibre Ltd. Holds 39th AGM, Approves Financials and Director Appointments
Aksh Optifibre Limited held its 39th AGM on September 28, 2026, approving annual financials and director appointments. The company is undergoing CIRP, with recent NCLAT orders impacting its operational management.
The AGM approvals are standard corporate procedures. However, the context of the ongoing Corporate Insolvency Resolution Process (CIRP) and the specific NCLAT order significantly impacts the company's operational and financial future, warranting a medium impact assessment.
The announcement details the outcomes of the AGM, including the approval of financial statements and director appointments. While these are routine corporate actions, the ongoing CIRP introduces an element of uncertainty, balancing out any positive or negative sentiment.
Aksh Optifibre Limited announced the outcome of its 39th Annual General Meeting (AGM), which was held on September 28, 2026, at 02:00 P.M. through Video Conferencing (VC) and Other Audio Visual Means (OAVM).
The meeting saw the approval of several key resolutions, including the adoption of the Annual Audited Financial Statements (Standalone & Consolidated) for the Financial Year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors.
Furthermore, the shareholders approved the re-appointment of Dr. Kailash Shantilal Choudhari as a Director, who retired by rotation and offered himself for re-appointment. The re-appointment of Mr. Satyendra Kumar Gupta as a Non-Executive Director and Professional Consultant of the Company was also approved.
Additionally, the remuneration of the Cost Auditor for the Financial Year ending March 31, 2027, was ratified. The company also submitted the Consolidated Report of Scrutinizer dated September 28, 2026, concerning remote e-Voting and the e-Voting conducted at the AGM.
It is noted that Aksh Optifibre Limited is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. An interim resolution professional was appointed by the NCLT, Jaipur Bench, on June 19, 2026. However, an appeal filed by the Promoter led to an NCLAT order on June 30, 2026, stating that the IRP shall not take further steps and the company will operate under the supervision of the IRP with the assistance of the Appellant and other company officers and employees.
What to do with a filing like this
Aksh Optifibre Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aksh Optifibre Limited. Read the original for the full detail.